155 related articles for article (PubMed ID: 17308683)
1. Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix.
Simionescu C; Georgescu CV; Mărgăritescu C; Niculescu M
Rom J Morphol Embryol; 2006; 47(3):245-9. PubMed ID: 17308683
[TBL] [Abstract][Full Text] [Related]
2. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions.
Michael H; Grawe L; Kraus FT
Int J Gynecol Pathol; 1984; 3(3):261-76. PubMed ID: 6500801
[TBL] [Abstract][Full Text] [Related]
3. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
5. [Minimal deviation endocervical adenocarcinoma--clinical, histologic and immunohistochemical study].
Zhang JM
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):275-7. PubMed ID: 2625109
[TBL] [Abstract][Full Text] [Related]
6. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
7. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
Pavlakis K; Messini I; Athanassiadou S; Kyrodimou E; Pandazopoulou A; Vrekoussis T; Stathopoulos EN
Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
Mikami Y; Kiyokawa T; Moriya T; Sasano H
Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
[TBL] [Abstract][Full Text] [Related]
9. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
[TBL] [Abstract][Full Text] [Related]
10. Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma).
Jones MA; Young RH; Scully RE
Am J Surg Pathol; 1991 Dec; 15(12):1123-9. PubMed ID: 1746679
[TBL] [Abstract][Full Text] [Related]
11. Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin.
Toki T; Shiozawa T; Hosaka N; Ishii K; Nikaido T; Fujii S
Int J Gynecol Pathol; 1997 Apr; 16(2):111-6. PubMed ID: 9100063
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological and immunohistochemical study of minimal deviation adenocarcinoma of the uterine cervix.
Zhu L; Yi X; Lin B; Gao A; Zhao W; Zhang Y; Li Y
Med Hypotheses; 2013 May; 80(5):643-8. PubMed ID: 23452641
[TBL] [Abstract][Full Text] [Related]
13. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
14. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
16. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
[TBL] [Abstract][Full Text] [Related]
17. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9].
Maruyama C; Yamamichi N; Konishi F
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714
[TBL] [Abstract][Full Text] [Related]
18. [Importance of the study of the expression of MIB-1 (Ki-67) for the diagnosis of endocervical glandular lesions].
Leteurtre E; Boman F; Farine MO; Leroy JL; Gosselin B
Ann Pathol; 1998 Jul; 18(3):172-7. PubMed ID: 9706342
[TBL] [Abstract][Full Text] [Related]
19. Benign endocervical cystic glandular change mimicking minimal deviation adenocarcinoma of the cervix on magnetic resonance imaging: a case report.
Bardsley M; Pather S; Neesham D; Dobrotwir A; Brown B; Quinn M; Grant P
Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):358-9. PubMed ID: 15282014
[No Abstract] [Full Text] [Related]
20. A case of microglandular adenocarcinoma of the endometrium.
Karateke A; Haliloglu B; Atay V; Gurbuz A; Kir G
Gynecol Oncol; 2005 Dec; 99(3):778-81. PubMed ID: 16229880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
